Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mina John

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Plos One|June 25, 2015
Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virusKatja Pfafferott, Pooja Deshpande, Elizabeth McKinnon, et al.
Genes and Immunity|November 18, 2016
HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesionsAmalia Magaret, Lichun Dong, Mina John, et al.
Pathology|June 28, 2018
Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western AustraliaGrace Thompson, Peter Boan, Jay Baumwol, et al.
Journal of Virology|November 19, 2010
Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteinsTomer Hertz, David Nolan, Ian James, et al.
Antiviral Therapy|November 18, 2009
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistanceMonika Tschochner, Abha Chopra, Tanya M Maiden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patientsMina John, Elizabeth J McKinnon, Ian R James, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2019
Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunityCoral-Ann Almeida, Paula van Miert, Kane O'Driscoll, et al.
Pathology|June 25, 2019
Autoantibodies in interstitial lung diseasesBrittany R Stevenson, Grace A Thompson, Monalyssa C Watson, et al.
The Journal of Infectious Diseases|September 12, 2013
Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencingHui Li, Lily Blair, Yalu Chen, et al.
AIDS (London, England)|January 2, 2013
HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopesCorine Bronke, Coral-Ann M Almeida, Elizabeth McKinnon, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Plos One|June 25, 2015
Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virusKatja Pfafferott, Pooja Deshpande, Elizabeth McKinnon, et al.
Genes and Immunity|November 18, 2016
HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesionsAmalia Magaret, Lichun Dong, Mina John, et al.
Pathology|June 28, 2018
Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western AustraliaGrace Thompson, Peter Boan, Jay Baumwol, et al.
Journal of Virology|November 19, 2010
Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteinsTomer Hertz, David Nolan, Ian James, et al.
Antiviral Therapy|November 18, 2009
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistanceMonika Tschochner, Abha Chopra, Tanya M Maiden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patientsMina John, Elizabeth J McKinnon, Ian R James, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2019
Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunityCoral-Ann Almeida, Paula van Miert, Kane O'Driscoll, et al.
Pathology|June 25, 2019
Autoantibodies in interstitial lung diseasesBrittany R Stevenson, Grace A Thompson, Monalyssa C Watson, et al.
The Journal of Infectious Diseases|September 12, 2013
Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencingHui Li, Lily Blair, Yalu Chen, et al.
AIDS (London, England)|January 2, 2013
HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopesCorine Bronke, Coral-Ann M Almeida, Elizabeth McKinnon, et al.
Pageof 8